Johnson Chemical Pharmaceutical Works Co., Ltd. (4747) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Johnson Chemical Pharmaceutical Works Co., Ltd. (4747:TWSE), powered by AI.

Current Price
$53.70
Sector
Healthcare
What is the Johnson Chemical Pharmaceutical Works Co., Ltd. stock price forecast?

Johnson Chemical Pharmaceutical Works Co., Ltd. is currently trading at $53.70. View real-time AI analysis on Alpha Lenz.

What is Johnson Chemical Pharmaceutical Works Co., Ltd. insider trading activity?

View the latest insider trading data for Johnson Chemical Pharmaceutical Works Co., Ltd. on Alpha Lenz.

What is Johnson Chemical Pharmaceutical Works Co., Ltd.'s P/E ratio?

View Johnson Chemical Pharmaceutical Works Co., Ltd.'s valuation metrics on Alpha Lenz.

Johnson Chemical Pharmaceutical Works Co., Ltd.

TWSE · 4747
NT$53.70+0.30(+0.56%)
Ask about Johnson Chemical Pharmaceutical Works Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Johnson Chemical Pharmaceutical Works Co., Ltd.'s ROE is 3.1%. Explore profitability and growth together.

Ask for details

Company Overview

Johnson Chemical Pharmaceutical Works Co., Ltd. is a pharmaceutical manufacturer specializing in the development and production of a broad array of therapeutic drugs. Established in 1959 and headquartered in New Taipei City, Taiwan, the company focuses on essential sectors within the healthcare industry, including pharmaceuticals targeting the central nervous system, respiratory and cardiovascular systems, gastrointestinal health, endocrine disorders, as well as vitamins and anti-inflammatory agents. Its offerings encompass various dosage forms, such as soft and hard capsules, coated and uncoated tablets, powders, granules, suppositories, and nasal sprays. Serving primarily the Taiwanese and broader Asian markets, Johnson Chemical Pharmaceutical Works is recognized for supplying both finished medications and pharmaceutical raw materials. With a workforce of over 170 employees, the company contributes significantly to the supply of generic and specialty medicines, supporting healthcare infrastructure across the region. Johnson Chemical Pharmaceutical Works Co., Ltd. plays a vital role in ensuring accessibility to a wide spectrum of medications, reflecting its longstanding presence and expertise in the pharmaceutical manufacturing landscape.

CEOMr. Baixiong Huang
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees170

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$569.77MRevenue
0.00Shares Out
170Employees

Margins

40.08%Gross
15.31%EBITDA
12.83%Operating
11.12%Pre-Tax
9.39%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

4.82%Rev 3Yr
6.09%Rev 5Yr
-4.02%Op Inc 3Yr
-0.65%Op Inc 5Yr
-6.21%Net Inc 3Yr
-3.39%Net Inc 5Yr

Returns

2.64%ROA
3.13%ROE
3.31%ROIC

Financial Health

NT$1.05BCash & Cash Equivalents
NT$-665.16MNet Debt
22.48%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Johnson Chemical Pharmaceutical Works Co., Ltd. (ticker: 4747) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 170 employees.

The current price is 53.7 with a P/E ratio of -x and P/B of -x.

ROE is 3.13% and operating margin is 12.83%. Annual revenue is $570M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Johnson Chemical Pharmaceutical Works Co., Ltd. (4747) Stock Forecast 2026 $53.70 — Price, Financials & Analyst Targets | Alpha Lenz